Point-of-Care Immunoassay Analyzer DCA Vantage 3 Tests CLIA Waived (HbA1c)

Por Mckesson
0
(0)
0 250
$7,243
Agotado

641021

Description

The DCA Vantage Analyzer is the diabetes system that delivers clinically proven, clinically relevant HbA1c and A:C Ratio results shown to improve patient compliance. Only 1uL of whole blood needed for HbA1c testing. HbA1c results in 6 minutes. Microalbumin testing allows for early detection of kidney disease results available in 7 minutes. Printed patient records and electronic transmission to LIS or electronic medical record allows for reduced transcription errors. Lot-specific calibration card provides automatic calibration with every cartridge. Storage Capacity/Memory: 4000 patient and/or control records and up to 1,000 operator IDs. Onboard Printer: 54 mm (2 in) width, thermal/label stock. CLIA Waived Hgb A1c. CLIA Moderate Complexity for Microalbumin and Creatinine


Specification

  • Application : Point-of-Care Immunoassay Analyzer
  • CLIA Classification : CLIA Waived (HbA1c)
  • Dimensions : 9 X 10 X 11-1/2 Inch
  • For Use With : For Immunoassay Cartridge
  • Number of Tests : 3 Tests
  • Power Source : 100 to 240VAC, 50/60 Hz, 70 VA, 30 Watts
  • Readout Type : Digital Display / Printer
  • Sample Capacity : 1 µL Whole Blood / 40 µL Urine Sample Volume
  • Sample Type : Whole Blood / Urine Sample
  • Test Name : Hemoglobin A1c, Albumin, Microalbumin/Creatinine, Creatinine, Albumin-to-Creatinine (A:C) Ratio
  • Time to Results : 6 Minute HbA1c Results / 7 Minute A:C Ratio Results
  • UNSPSC Code : 41115819
  • User Interface : Color Touch Screen Display / Bar Code Reader
  • Weight : 9 lbs.
Vendor McKesson
Rango de precios $3,001 - $4,000
Costo de envío
Ubicación de la tienda Irving, Texas (TX), United States (US)

No se encontraron opiniones!

No se han encontrado comentarios para este producto. ¡Sé el primero en comentar!

Welcome to shop.mhsurgicals.com..! In order to provide a more relevant experience for you, we use cookies to enable some website functionality. Cookies help us see which articles most interest you. This website or its third-party tools process personal data (e.g. browsing data or IP addresses) and use cookies or other identifiers, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy.

You accept the use of cookies by closing or dismissing this notice, To learn more, please refer to the Cookie policy.